{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:15:22Z","timestamp":1787494522608,"version":"build-2736575974"},"reference-count":65,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","clinical-breast-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clbc.2024.04.009","type":"journal-article","created":{"date-parts":[[2024,4,20]],"date-time":"2024-04-20T01:45:17Z","timestamp":1713577517000},"page":"385-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["De-escalation of Axillary Surgery After Neoadjuvant Therapy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-1701-8771","authenticated-orcid":false,"given":"Casey","family":"Connors","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahraa","family":"Al-Hilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.clbc.2024.04.009_bib0001","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00000658-189407000-00075","article-title":"The results of operations for the cure of cancer of the breast performed at the Johns Hopkins hospital from June, 1889, to January, 1894","volume":"20","author":"Halsted","year":"1894","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.clbc.2024.04.009_bib0002","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJM198503143121102","article-title":"Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation","volume":"312","author":"Fisher","year":"1985","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.clbc.2024.04.009_bib0003","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa020128","article-title":"Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation","volume":"347","author":"Fisher","year":"2002","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10549-005-9025-7","article-title":"Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer","volume":"95","author":"Fleissig","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0006","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0960-7404(93)90064-6","article-title":"Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe","volume":"2","author":"Krag","year":"1993","journal-title":"Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2024.04.009_bib0007","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S1470-2045(10)70207-2","article-title":"Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial","volume":"11","author":"Krag","year":"2010","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.009_bib0008","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1200\/JCO.2016.71.0947","article-title":"Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology Clinical Practice Guideline Update","volume":"35","author":"Lyman","year":"2017","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0009","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1001\/jama.2011.90","article-title":"Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial","volume":"305","author":"Giuliano","year":"2011","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0010","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.clbc.2024.04.009_bib0011","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S1470-2045(18)30380-2","article-title":"Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial","volume":"19","author":"Galimberti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.009_bib0012","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1200\/JCO.22.01565","article-title":"Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer: 10-year results of the randomized controlled EORTC 10981-22023 AMAROS trial","volume":"41","author":"Bartels","year":"2023","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2024.04.009_bib0013","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1200\/JCO.1997.15.7.2483","article-title":"Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18","volume":"15","author":"Fisher","year":"1997","journal-title":"J Clin Oncol"},{"issue":"16","key":"10.1016\/j.clbc.2024.04.009_bib0014","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1200\/JCO.2007.15.0235","article-title":"Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27 [published correction appears in","volume":"26","author":"Rastogi","year":"2008","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.009_bib0015","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/SLA.0000000000000924","article-title":"Tumor biology correlates with rates of breast-conserving surgery and pathologic complete response after neoadjuvant chemotherapy for breast cancer: findings from the ACOSOG Z1071 (Alliance) Prospective Multicenter Clinical Trial","volume":"260","author":"Boughey","year":"2014","journal-title":"Ann Surg"},{"issue":"9","key":"10.1016\/j.clbc.2024.04.009_bib0016","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1056\/NEJMoa1910549","article-title":"Pembrolizumab for early triple-negative breast cancer","volume":"382","author":"Schmid","year":"2020","journal-title":"N Engl J Med"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.009_bib0017","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1002\/cncr.25152","article-title":"Cytologically proven axillary lymph node metastases are eradicated in patients receiving preoperative chemotherapy with concurrent trastuzumab for HER2-positive breast cancer","volume":"116","author":"Dominici","year":"2010","journal-title":"Cancer"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0018","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/SLA.0000000000003075","article-title":"Diagnostic accuracy of different surgical procedures for axillary staging after neoadjuvant systemic therapy in node-positive breast cancer: a systematic review and meta-analysis","volume":"269","author":"Simons","year":"2019","journal-title":"Ann Surg"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0019","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2021.0891","article-title":"Axillary pathologic complete response after neoadjuvant systemic therapy by breast cancer subtype in patients with initially clinically node-positive disease: a systematic review and meta-analysis","volume":"156","author":"Samiei","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/j.clbc.2024.04.009_bib0020","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10549-023-07152-2","article-title":"Nodal pCR and overall survival following neoadjuvant chemotherapy for node positive ER+\/Her2- breast cancer","volume":"203","author":"Moldoveanu","year":"2023","journal-title":"Breast Cancer Res Treat"},{"issue":"13","key":"10.1016\/j.clbc.2024.04.009_bib0021","doi-asserted-by":"crossref","first-page":"4326","DOI":"10.1245\/s10434-019-07785-y","article-title":"Patterns of axillary management in stages 2 and 3 hormone receptor-positive breast cancer by initial treatment approach","volume":"26","author":"Weiss","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"10.1016\/j.clbc.2024.04.009_bib0022","doi-asserted-by":"crossref","first-page":"4702","DOI":"10.1245\/s10434-020-08888-7","article-title":"How effective is neoadjuvant endocrine therapy (NET) in downstaging the axilla and achieving breast-conserving surgery?","volume":"27","author":"Montagna","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2024.04.009_bib0023","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejso.2021.04.041","article-title":"Rate and predictors of nodal pathological complete response following neoadjuvant endocrine treatment in clinically biopsy-proven node-positive breast cancer patients","volume":"47","author":"Schipper","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2024.04.009_bib0024","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa1814017","article-title":"Trastuzumab emtansine for residual invasive HER2-positive breast cancer","volume":"380","author":"von Minckwitz","year":"2019","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.clbc.2024.04.009_bib0025","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1056\/NEJMoa1612645","article-title":"Adjuvant capecitabine for breast cancer after preoperative chemotherapy","volume":"376","author":"Masuda","year":"2017","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.clbc.2024.04.009_bib0026","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1200\/JCO.2004.11.141","article-title":"Tree-based model for breast cancer prognostication","volume":"22","author":"Banerjee","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0027","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2214\/AJR.07.2460","article-title":"Cortical morphologic features of axillary lymph nodes as a predictor of metastasis in breast cancer: in vitro sonographic study","volume":"191","author":"Bedi","year":"2008","journal-title":"AJR Am J Roentgenol"},{"issue":"2","key":"10.1016\/j.clbc.2024.04.009_bib0028","doi-asserted-by":"crossref","first-page":"e231","DOI":"10.1634\/theoncologist.2019-0427","article-title":"Lymph node imaging in patients with primary breast cancer: concurrent diagnostic tools","volume":"25","author":"Marino","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.clbc.2024.04.009_bib0029","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/sj.bjc.6601290","article-title":"Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancer","volume":"89","author":"Damera","year":"2003","journal-title":"Br J Cancer"},{"issue":"11","key":"10.1016\/j.clbc.2024.04.009_bib0030","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1007\/s00330-016-4235-4","article-title":"Preoperative axillary lymph node evaluation in breast cancer patients by breast magnetic resonance imaging (MRI): Can breast MRI exclude advanced nodal disease?","volume":"26","author":"Hyun","year":"2016","journal-title":"Eur Radiol"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.009_bib0031","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.009_bib0032","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ejso.2020.10.014","article-title":"Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up","volume":"47","author":"Kahler-Ribeiro-Fontana","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2024.04.009_bib0033","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162605","article-title":"The feasibility and accuracy of sentinel lymph node biopsy in initially clinically node-negative breast cancer after neoadjuvant chemotherapy: a systematic review and meta-analysis","volume":"11","author":"Geng","year":"2016","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clbc.2024.04.009_bib0034","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1001\/jamaoncol.2016.4163","article-title":"Axillary nodal management following neoadjuvant chemotherapy: a review","volume":"3","author":"Pilewskie","year":"2017","journal-title":"JAMA Oncol"},{"issue":"14","key":"10.1016\/j.clbc.2024.04.009_bib0035","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.2013.278932","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial","volume":"310","author":"Boughey","year":"2013","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.clbc.2024.04.009_bib0036","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S1470-2045(13)70166-9","article-title":"Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study","volume":"14","author":"Kuehn","year":"2013","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0037","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1200\/JCO.2014.55.7827","article-title":"Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study","volume":"33","author":"Boileau","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.04.009_bib0038","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s10549-018-5004-7","article-title":"Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study","volume":"173","author":"Classe","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0039","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1097\/SLA.0000000000000551","article-title":"Factors affecting sentinel lymph node identification rate after neoadjuvant chemotherapy for breast cancer patients enrolled in ACOSOG Z1071 (Alliance)","volume":"261","author":"Boughey","year":"2015","journal-title":"Ann Surg"},{"issue":"11","key":"10.1016\/j.clbc.2024.04.009_bib0040","doi-asserted-by":"crossref","first-page":"6401","DOI":"10.1245\/s10434-023-13759-y","article-title":"Changes in surgical management of the axilla over 11 years - report on more than 1500 breast cancer patients treated with neoadjuvant chemotherapy on the prospective i-SPY2 trial","volume":"30","author":"Boughey","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2024.04.009_bib0041","unstructured":"National Comprehensive Cancer Network. Breast Cancer (Version 2.2024). https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf. Accessed Feb 10, 2024."},{"issue":"5","key":"10.1016\/j.clbc.2024.04.009_bib0042","doi-asserted-by":"crossref","first-page":"e553","DOI":"10.1097\/SLA.0000000000004572","article-title":"A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients","volume":"276","author":"Kuemmel","year":"2022","journal-title":"Ann Surg"},{"issue":"10","key":"10.1016\/j.clbc.2024.04.009_bib0043","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1245\/s10434-017-6023-z","article-title":"Localizing the clipped node in patients with node-positive breast cancer treated with neoadjuvant chemotherapy: early learning experience and challenges","volume":"24","author":"Nguyen","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0044","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1245\/s10434-017-6270-z","article-title":"Intraoperative ultrasound-guided excision of axillary clip in patients with node-positive breast cancer treated with neoadjuvant therapy (ILINA Trial) : a new tool to guide the excision of the clipped node after neoadjuvant treatment","volume":"25","author":"Siso","year":"2018","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.clbc.2024.04.009_bib0045","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1245\/s10434-019-07419-3","article-title":"Pretreatment tattoo marking of suspicious axillary lymph nodes: reliability and correlation with sentinel lymph node","volume":"26","author":"Patel","year":"2019","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2024.04.009_bib0046","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.suronc.2020.11.013","article-title":"Advantages of preoperative localization and surgical resection of metastatic axillary lymph nodes using magnetic seeds after neoadjuvant chemotherapy in breast cancer","volume":"36","author":"Mariscal Mart\u00ednez","year":"2021","journal-title":"Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.009_bib0047","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12957-023-03147-x","article-title":"Ideal marker for targeted axillary dissection (IMTAD): a prospective multicentre trial","volume":"21","author":"\u017dateck\u00fd","year":"2023","journal-title":"World J Surg Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2024.04.009_bib0048","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1245\/s10434-022-12240-6","article-title":"Is nodal clipping beneficial for node-positive breast cancer patients receiving neoadjuvant chemotherapy?","volume":"29","author":"Montagna","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0049","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1245\/s10434-018-6429-2","article-title":"Is low-volume disease in the sentinel node after neoadjuvant chemotherapy an indication for axillary dissection?","volume":"25","author":"Moo","year":"2018","journal-title":"Ann Surg Oncol."},{"key":"10.1016\/j.clbc.2024.04.009_bib0050","unstructured":"Montagna M, Weber W, et al. Nodal burden and nodal recurrence in patients with isolated tumor cells after neoadjuvant chemotherapy treated with axillary dissection or axillary radiation: the OPBC-05\/EUBREAST-14R\/ICARO study"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0051","doi-asserted-by":"crossref","first-page":"531","DOI":"10.4048\/jbc.2021.24.e48","article-title":"Sentinel lymph node biopsy in breast cancer patients with pathological complete response in the axillary lymph node after neoadjuvant chemotherapy","volume":"24","author":"Kim","year":"2021","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clbc.2024.04.009_bib0052","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.1245\/s10434-019-07540-3","article-title":"Patterns in the use of axillary operations for patients with node-positive breast cancer after neoadjuvant chemotherapy: a National Cancer Database (NCDB) analysis","volume":"26","author":"Srour","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.clbc.2024.04.009_bib0053","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","article-title":"Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation","volume":"14","author":"Thompson","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.009_bib0054","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.clbc.2022.10.008","article-title":"Axillary reverse mapping in the prevention of lymphoedema: a systematic review and pooled analysis","volume":"23","author":"Co","year":"2023","journal-title":"Clin Breast Cancer"},{"issue":"10","key":"10.1016\/j.clbc.2024.04.009_bib0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.05.012","article-title":"The involvement of axillary reverse mapping nodes in patients with node-positive breast cancer","volume":"49","author":"Noguchi","year":"2023","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.clbc.2024.04.009_bib0056","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/j.ejso.2020.10.031","article-title":"Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer","volume":"47","author":"Gennaro","year":"2021","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2024.04.009_bib0057","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/jso.25513","article-title":"Axillary reverse mapping and lymphaticovenous bypass: lymphedema prevention through enhanced lymphatic visualization and restoration of flow","volume":"120","author":"Schwarz","year":"2019","journal-title":"J Surg Oncol"},{"issue":"5","key":"10.1016\/j.clbc.2024.04.009_bib0058","doi-asserted-by":"crossref","first-page":"773e","DOI":"10.1097\/PRS.0000000000010381","article-title":"A 4-year institutional experience of immediate lymphatic reconstruction","volume":"152","author":"Granoff","year":"2023","journal-title":"Plast Reconstr Surg"},{"issue":"2","key":"10.1016\/j.clbc.2024.04.009_bib0059","doi-asserted-by":"crossref","first-page":"e278","DOI":"10.1097\/AS9.0000000000000278","article-title":"Prophylactic lymphovenous bypass at the time of axillary lymph node dissection decreases rates of lymphedema","volume":"4","author":"Deldar","year":"2023","journal-title":"Ann Surg Open"},{"issue":"3","key":"10.1016\/j.clbc.2024.04.009_bib0060","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1007\/s10549-022-06758-2","article-title":"Oncologic safety of axillary lymph node dissection with immediate lymphatic reconstruction","volume":"196","author":"Guzzo","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2024.04.009_bib0061","unstructured":"Wolmark N. Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery. 2013, August. ClinicalTrials.gov ID NCT01872975. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01872975."},{"key":"10.1016\/j.clbc.2024.04.009_bib0062","unstructured":"Goyal A. Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant Chemotherapy (ATNEC). 2021, February. ClinicalTrials.gov ID NCT01409079. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04109079."},{"key":"10.1016\/j.clbc.2024.04.009_bib0063","unstructured":"Boughey J. Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With Chemotherapy. 2014, February. ClinicalTrials.gov ID NCT01901094. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT01901094."},{"issue":"7","key":"10.1016\/j.clbc.2024.04.009_bib0064","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.3390\/cancers13071565","article-title":"Surgical management of the axilla in clinically node-positive breast cancer patients converting to clinical node negativity through neoadjuvant chemotherapy: current status, knowledge gaps, and rationale for the EUBREAST-03 AXSANA study","volume":"13","author":"Banys-Paluchowski","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.clbc.2024.04.009_bib0065","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1186\/s13063-018-3021-9","article-title":"Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial","volume":"19","author":"Henke","year":"2018","journal-title":"Trials"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820924001083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T10:54:06Z","timestamp":1718880846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820924001083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":65,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1526820924001083"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2024.04.009","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"De-escalation of Axillary Surgery After Neoadjuvant Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2024.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}